The Lundquist Institute at Harbor-UCLA Medical Center

Torrance, California 90509

1 studies enrolling now · 9 studies all time

What they study most

Acute Stroke, Arthritis, Rheumatoid, Diverticulosis, Colonic, Endometrial Related Pain, Ischemic Stroke, Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis VI, Stroke, Systemic Lupus Erythematosus

Studies at this site

• Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) — Recruiting now
• The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) — Running, not enrolling
• Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis — Withdrawn before enrolling
• Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI — Running, not enrolling
• Safety and Efficacy Study of MT-2990 in Women With Endometriosis — Completed
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed
• Open-label Study of Anakinra in MPS III — Completed
• L-glutamine Treatment in Patients With Diverticulosis — Completed
• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed